デフォルト表紙
市場調査レポート
商品コード
938826

血栓管理デバイスの世界市場

Clot Management Devices

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=136.22円
血栓管理デバイスの世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の血栓管理の市場は、新型コロナウイルス感染症 (COVID-19) の世界的流行とそれに伴う経済不況の中、予測期間中4.4%のCAGRで推移すると予測されています。デバイスタイプ別では、脳血管血栓除去部門が同期間中5.7%を超えるCAGRで成長する見通しです。歴史上例のないCOVID-19の大流行は、あらゆる産業にかつて経験したことのない様々な影響を及ぼしています。、脳血管血栓除去デバイス部門も、ポストCOVID-19時代に向けたニューノーマル(新常態)を構築することとなるでしょう。新たなシナリオで見ると、地域別では、米国が5.3%のCAGRで推移する見通しです。欧州の中で大流行の影響を大きく受けたドイツの市場規模は、今後7-8年で2810万米ドルを超える規模の拡大を示す見通しです。また他の欧州地域では、2300万米ドルを超える規模の需要が見込まれています。一方、日本の脳血管血栓除去デバイス市場は予測期間末までに4460万米ドルの市場規模に成長する見通しです。また、今回の大流行の発端となり深刻な政治的および経済的課題に直面する中国は、さまざまな障壁にもかかわらず、今後数年間で4.3%の成長を示す見通しです。

調査対象企業の例

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

当レポートでは、世界の血栓管理デバイスの市場を調査し、市場および製品の概要、市場成長への各種影響因子の分析、市場規模の推移と予測、各種区分・地域・主要国別の詳細分析、競合環境、主要企業プロファイルなどをまとめています。

I イントロダクション・調査手法・調査範囲

II エグゼクティブサマリー

第1章 市場概要

  • Covid-19の影響・景気後退の見通し

第2章 主要企業

第3章 市場動向・成長推進因子

第4章 世界市場の展望

III 市場分析

  • 市場分析:地域・主要国別

IV 競合

  • 企業プロファイル
目次
Product Code: MCP11053

Abstract:

Global Clot Management Devices Market to Reach $2 Billion by 2027

Amid the COVID-19 crisis, the global market for Clot Management Devices estimated at US$1.5 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027. Neurovascular Embolectomy Devices, one of the segments analyzed in the report, is projected to record a 5.7% CAGR and reach US$423.1 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Percutaneous Thrombectomy Devices segment is readjusted to a revised 4.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $442.7 Million, While China is Forecast to Grow at 4.1% CAGR

The Clot Management Devices market in the U.S. is estimated at US$442.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$359.1 Million by the year 2027 trailing a CAGR of 4.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.2% and 3.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Embolectomy Balloon Catheters Segment to Record 3.4% CAGR

In the global Embolectomy Balloon Catheters segment, USA, Canada, Japan, China and Europe will drive the 3.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$91.2 Million in the year 2020 will reach a projected size of US$116 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$225.6 Million by the year 2027.

Select Competitors (Total 43 Featured) -

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 2: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 3: World 15-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 5: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 6: World 15-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 8: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 9: World 15-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 11: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 12: World 15-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 14: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 15: World 15-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 17: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 18: World 15-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
    • TABLE 22: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 24: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 25: USA Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 26: USA Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 27: USA 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 28: USA Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 29: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 30: USA 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 31: Canada Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 32: Canada Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 33: Canada 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 34: Canada Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 35: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 36: Canada 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 37: Japan Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 38: Japan Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 39: Japan 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 40: Japan Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 41: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 42: Japan 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 43: China Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 44: China Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 45: China 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 46: China Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 47: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 48: China 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • EUROPE
    • TABLE 49: Europe Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
    • TABLE 50: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 51: Europe 15-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 53: Europe Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 54: Europe 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 55: Europe Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 57: Europe 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 58: France Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 59: France Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 60: France 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 61: France Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 62: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 63: France 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 64: Germany Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 65: Germany Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 66: Germany 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 67: Germany Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 68: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 69: Germany 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 70: Italy Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 71: Italy Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 72: Italy 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 73: Italy Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 74: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 75: Italy 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 76: UK Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 77: UK Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 78: UK 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 79: UK Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 80: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 81: UK 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 82: Rest of Europe Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 83: Rest of Europe Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 84: Rest of Europe 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 85: Rest of Europe Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 86: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 87: Rest of Europe 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 88: Asia-Pacific Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 89: Asia-Pacific Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 90: Asia-Pacific 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 91: Asia-Pacific Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 92: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 93: Asia-Pacific 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027
  • REST OF WORLD
    • TABLE 94: Rest of World Current & Future Analysis for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 95: Rest of World Historic Review for Clot Management Devices by Segment - Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 96: Rest of World 15-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) Devices and Inferior Vena Cava Filters (IVCF) for the Years 2012, 2020 & 2027
    • TABLE 97: Rest of World Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
    • TABLE 98: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
    • TABLE 99: Rest of World 15-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 43